- $32.60m
- -$16.45m
- $11.00m
Annual balance sheet for Bioatla, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 239 | 245 | 216 | 111 | 49 |
| Prepaid Expenses | |||||
| Total Current Assets | 241 | 247 | 220 | 116 | 51.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.1 | 6.98 | 5.15 | 3.1 | 1.19 |
| Other Long Term Assets | |||||
| Total Assets | 245 | 254 | 226 | 120 | 52.4 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 32.3 | 19.8 | 23.1 | 28.3 | 14.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 35 | 43.6 | 45.4 | 49 | 38.2 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 210 | 211 | 180 | 70.7 | 14.3 |
| Total Liabilities & Shareholders' Equity | 245 | 254 | 226 | 120 | 52.4 |
| Total Common Shares Outstanding |